Cardiomyopathy Tissue Bank in a Cancer Population
2 Months
N/A
Both
Heart Disease
Trial Information
Cardiomyopathy Tissue Bank in a Cancer Population
You will have a one time blood draw of 2 teaspoons of blood for use in future research.
This blood may be studied in the future to try to find possible genetic or biochemical
markers that may be the cause of CHF. Your blood will be drawn either on an outpatient
basis or during a routine visit to the hospital. If you already have a central line or an
IV placed, the blood will be drawn at these sites to decrease the pain and discomfort of the
blood draw. The information obtained in this study will not be put into your medical
records.
This is an investigational study. All will be enrolled at M. D. Anderson.
Inclusion Criteria:
- Patients who are at high risk for developing Cardiomyopathy or Congestive Heart
Failure.
- Patients two months of age and older.
Exclusion Criteria:
- Those that are not willing to sign an informed consent.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Baseline Patient Demographic Information (age, sex, race)
Outcome Time Frame:
One time visit.
Safety Issue:
No
Principal Investigator
Jean-Bernard Durand, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
M.D. Anderson Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
ID02-359
NCT ID:
NCT00500734
Start Date:
December 2002
Completion Date:
Related Keywords:
- Heart Disease
- Cardiomyopathy
- Tissue Bank
- Heart Disease
- Heart Failure
- Congestive Heart Failure
- Heart Diseases
- Cardiomyopathies
Name | Location |
|---|---|
| UT MD Anderson Cancer Center | Houston, Texas 77030 |
